Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR3 | P51677 | 1/20 | 0.69 |
| ▸ | SIGMAR1 | Q99720 | 4/20 | 0.67 |
| ▸ | MC4R | P32245 | 1/20 | 0.67 |
| ▸ | LMNA | P02545 | 1/20 | 0.59 |
| ▸ | POLB | P06746 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13632432 | 1.00 | CCR3 (0.69) | CCR3SIGMAR1MC4RLMNAPOLB | |
| SCHEMBL6740759 | 1.00 | CCR3 (0.69) | CCR3SIGMAR1MC4RLMNAPOLB | |
| SCHEMBL1244038 | 0.95 | CCR3 (0.72) | CCR3SIGMAR1MC4RLMNAPOLB | |
| SCHEMBL12040820 | 0.93 | CCR3 (0.70) | CCR3SIGMAR1MC4RLMNAPOLB | |
| SCHEMBL8723260 | 0.93 | CCR3 (0.70) | CCR3SIGMAR1MC4RLMNAPOLB | |
| SCHEMBL15800706 | 0.93 | CCR3 (0.70) | CCR3SIGMAR1MC4RLMNAPOLB | |
| SCHEMBL8097472 | 0.89 | SIGMAR1 (0.72) | CCR3SIGMAR1MC4RLMNAPOLB | |
| SCHEMBL6744977 | 0.89 | SIGMAR1 (0.72) | CCR3SIGMAR1MC4RLMNAPOLB | |
| SCHEMBL19169973 | 0.89 | SIGMAR1 (0.72) | CCR3SIGMAR1MC4R | |
| SCHEMBL12040822 | 0.89 | CCR3 (0.64) | CCR3SIGMAR1MC4RLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170210714-A1 | MACROCYCLIC COMPLEXES, THEIR PROCESS OF PREPARATION AND USE AS PET IMAGING AGENTS | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 2017-07-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170210714-A1 | MACROCYCLIC COMPLEXES, THEIR PROCESS OF PREPARATION AND USE AS PET IMAGING AGENTS | MPI, PAICS, TFEB | CCR3 432/4885SIGMAR1 2616/4885MC4R 213/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.